Macroaxis gives Seattle performance score of 0 on a scale of 0 to 100. The firm has beta of 2.1 which indicates as market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Seattle will likely underperform. Even though it is essential to pay attention to
Seattle Genetics current price movements, it is always good to be careful when utilizing equity historical returns. Macroaxis philosophy towards measuring future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available
technical indicators. Seattle Genetics Inc exposes twenty-eight different technical indicators which can help you to evaluate its performance.
Seattle Genetics has expected return of -0.47%. Please be advised to validate Seattle
Value At Risk, and the
relationship between
Jensen Alpha and
Skewness to decide if
Seattle Genetics past performance will be repeated at some point in the near future.
|
Investment horizon:
|
30 Days
Login
to change
|
|
|
Relative Risk vs. Return Landscape
If you would invest
3,573 in Seattle Genetics Inc on
May 20, 2013 and sell it today you would
lose (353.00) from holding Seattle Genetics Inc or give up
9.88% of portfolio value over
30 days. Seattle Genetics Inc is currenly does not generate positive expected returns and assumes 2.37% risk (volatility on return distribution) over the 30 days horizon. In different words, 29% of equities are less volatile than Seattle Genetics Inc and 99% of traded equity instruments are projected to make higher returns than the company over the 30 days investment horizon.
Daily Expected Return (%)
Given investment horizon of 30 days, Seattle Genetics Inc is expected to under-perform the market. In addition to that, the company is 2.82 times more volatile than its market benchmark. It trades about -0.2 of its total potential returns per unit of risk. The S&P 500 is currently generating roughly -0.05 per unit of volatility.
Seattle Operating Margin
Based on recorded statements Seattle Genetics Inc has Operating Margin of -26.44%. This is 7.62% lower than that of Healthcare sector, and 73.39% lower than that of
Biotechnology industry, The Operating Margin for all stocks is 599.47% higher than the company.
A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.
Seattle Return On Equity vs Return On Asset
Seattle Genetics Inc is rated
below average in return on equity category among related companies. It is rated
below average in return on asset category among related companies .
-0.14% 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
